| Primary |
| Epilepsy |
44.9% |
| Convulsion |
12.2% |
| Trigeminal Neuralgia |
9.0% |
| Hypertension |
5.7% |
| Depression |
3.4% |
| Bipolar Disorder |
3.2% |
| Pain |
2.6% |
| Schizophrenia |
2.3% |
| Neuralgia |
1.9% |
| Insomnia |
1.8% |
| Partial Seizures |
1.7% |
| Constipation |
1.6% |
| Bipolar I Disorder |
1.5% |
| Asthma |
1.3% |
| Temporal Lobe Epilepsy |
1.3% |
| Diabetes Mellitus |
1.3% |
| Anxiety |
1.2% |
| Grand Mal Convulsion |
1.1% |
| Affective Disorder |
1.0% |
| Gastritis |
0.9% |
|
| Maternal Exposure During Pregnancy |
11.6% |
| Vomiting |
10.9% |
| Convulsion |
10.1% |
| Somnolence |
7.4% |
| White Blood Cell Count Increased |
6.7% |
| White Blood Cell Count Decreased |
5.8% |
| Suicide Attempt |
5.3% |
| Pyrexia |
4.8% |
| Rash |
4.5% |
| Stevens-johnson Syndrome |
3.7% |
| Drug Exposure During Pregnancy |
3.6% |
| Epilepsy |
3.5% |
| Urticaria |
3.4% |
| Tremor |
3.3% |
| Stillbirth |
2.9% |
| Pain |
2.6% |
| Weight Increased |
2.6% |
| Vision Blurred |
2.4% |
| Loss Of Consciousness |
2.4% |
| Weight Decreased |
2.2% |
|
| Secondary |
| Epilepsy |
32.4% |
| Product Used For Unknown Indication |
11.9% |
| Drug Use For Unknown Indication |
8.1% |
| Convulsion |
7.4% |
| Trigeminal Neuralgia |
5.4% |
| Depression |
5.0% |
| Hypertension |
4.6% |
| Pain |
4.1% |
| Bipolar Disorder |
3.4% |
| Constipation |
2.6% |
| Insomnia |
2.0% |
| Schizophrenia |
1.8% |
| Cerebral Infarction |
1.7% |
| Anxiety |
1.6% |
| Partial Seizures |
1.5% |
| Affective Disorder |
1.4% |
| Bipolar I Disorder |
1.4% |
| Neuralgia |
1.2% |
| Foetal Exposure During Pregnancy |
1.2% |
| Brief Psychotic Disorder With Marked Stressors |
1.1% |
|
| Vomiting |
12.4% |
| Convulsion |
7.7% |
| Somnolence |
6.9% |
| White Blood Cell Count Decreased |
6.9% |
| White Blood Cell Count Increased |
6.4% |
| Stevens-johnson Syndrome |
6.3% |
| Weight Decreased |
5.4% |
| Weight Increased |
5.4% |
| Tremor |
4.6% |
| Hyponatraemia |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Vision Blurred |
3.8% |
| Malaise |
3.6% |
| Rash |
3.6% |
| Drug Hypersensitivity |
3.5% |
| Suicide Attempt |
3.4% |
| Epilepsy |
3.3% |
| Pyrexia |
3.2% |
| Nausea |
3.0% |
| Toxic Epidermal Necrolysis |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.3% |
| Epilepsy |
13.6% |
| Drug Use For Unknown Indication |
9.7% |
| Convulsion |
7.1% |
| Depression |
6.2% |
| Pain |
5.6% |
| Bipolar Disorder |
5.5% |
| Multiple Sclerosis |
4.8% |
| Hypertension |
4.7% |
| Complex Partial Seizures |
3.0% |
| Simple Partial Seizures |
2.9% |
| Schizophrenia |
2.4% |
| Relapsing-remitting Multiple Sclerosis |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Partial Seizures With Secondary Generalisation |
2.2% |
| Anxiety |
2.2% |
| Trigeminal Neuralgia |
2.1% |
| Insomnia |
2.0% |
| Prophylaxis |
1.9% |
| Asthma |
1.9% |
|
| Vomiting |
10.1% |
| Weight Increased |
10.0% |
| Weight Decreased |
9.0% |
| Convulsion |
8.0% |
| Somnolence |
5.8% |
| Type 2 Diabetes Mellitus |
5.7% |
| White Blood Cell Count Decreased |
5.4% |
| Pyrexia |
4.9% |
| Epilepsy |
4.6% |
| Urinary Tract Infection |
4.3% |
| Tremor |
4.1% |
| Rash |
4.0% |
| Pain |
3.5% |
| Nausea |
3.4% |
| Drug Ineffective |
3.1% |
| Suicidal Ideation |
3.0% |
| Death |
2.8% |
| Status Epilepticus |
2.8% |
| Vision Blurred |
2.8% |
| Pneumonia |
2.7% |
|
| Interacting |
| Epilepsy |
24.4% |
| Schizophrenia |
12.1% |
| Product Used For Unknown Indication |
11.4% |
| Drug Use For Unknown Indication |
10.3% |
| Lymphoma |
5.5% |
| Hypertension |
5.1% |
| Convulsion |
4.0% |
| Partial Seizures |
3.6% |
| Pain |
2.9% |
| Constipation |
2.6% |
| Depression |
2.2% |
| Heart Transplant |
2.2% |
| Schizophrenia, Paranoid Type |
2.1% |
| Hiv Infection |
1.9% |
| Prophylaxis |
1.9% |
| Trigeminal Neuralgia |
1.9% |
| Complex Partial Seizures |
1.6% |
| Convulsion Prophylaxis |
1.6% |
| Insomnia |
1.6% |
| Neuralgia |
1.2% |
|
| Drug Interaction |
25.0% |
| Somnolence |
10.3% |
| Nausea |
5.8% |
| Hyponatraemia |
5.1% |
| Visual Impairment |
5.1% |
| Tremor |
4.5% |
| Weight Decreased |
4.5% |
| Epilepsy |
3.8% |
| Soliloquy |
3.8% |
| Speech Disorder |
3.8% |
| White Blood Cells Urine Positive |
3.8% |
| Withdrawal Syndrome |
3.8% |
| Paraesthesia |
3.2% |
| Toxicity To Various Agents |
3.2% |
| Anticonvulsant Drug Level Increased |
2.6% |
| Blood Amylase Increased |
2.6% |
| Incoherent |
2.6% |
| Vomiting |
2.6% |
| Accidental Overdose |
1.9% |
| Immunosuppressant Drug Level Increased |
1.9% |
|
